Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Medtronic
Merck
McKesson
Dow

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Litigation Details for Gilead Sciences, Inc. v. Lupin Limited (S.D.N.Y. 2014)

See Plans and Pricing

« Back to Dashboard

Gilead Sciences, Inc. v. Lupin Limited (S.D.N.Y. 2014)

Docket   See Pricing Date Filed 2014-07-16
Court District Court, S.D. New York Date Terminated 2014-09-17
Cause 35:271 Patent Infringement Assigned To Richard Joseph Sullivan
Jury Demand Defendant Referred To
Parties EMORY UNIVERSITY; GILEAD SCIENCES, INC.,; LUPIN LIMITED
Patents 6,642,245; 6,703,396
Attorneys Christopher P. Borello; Colleen Tracy James; David B. Bassett; Jill Catherine Owens; Nicholas M. Cannella; Peter DeForest Shapiro; Peter J. Curtin
Link to Docket External link to docket
Small Molecule Drugs cited in Gilead Sciences, Inc. v. Lupin Limited
The small molecule drugs covered by the patents cited in this case are   See Pricing ,   See Pricing ,   See Pricing ,   See Pricing ,   See Pricing ,   See Pricing ,   See Pricing ,   See Pricing ,   See Pricing , and   See Pricing .
Biologic Drugs cited in Gilead Sciences, Inc. v. Lupin Limited
The biologic drug covered by the patents cited in this case is   See Pricing .

Details for Gilead Sciences, Inc. v. Lupin Limited (S.D.N.Y. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-07-16 1 trademark Atripla®. 16. United States.Patent No. 6,642,245 (“the ’245 Patent,” copy attached as Exhibit A), …Infringement of U.S. Patent No. 6,642,245 23. Plaintiffs repeat and reallege paragraphs 1-22 above as …Action l. This is an action for patent infringement under the patent laws of the United States, Title…the United States Patent and Trademark Office on Nover-nber 4, 2003. The ’245 Patent claims, inter alia…for Atripla®. 17. United States Patent No. 6,703,396 (“the ’396 Patent,” copy attached as Exhibit B), External link to document
2014-08-22 13 States Patent and Trademark Office (“PTO”), the PTO issued United States Patent No. 6,642,245 B1 (“the…Trademark Office issued U.S. Patent No. 6,642,245 B1 (“the ‘245 patent”), entitled “ANTIVIRAL ACTIVITY… U.S. Patent No. 6,642,245 23. Lupin restates and incorporates… the PTO issued United States Patent No. 6,703,396 B1 (“the ‘396 patent”), titled “METHOD OF RESOLUTION… Patents-in-Suit 8. On or about November 4, 2003, the United States Patent and Trademark External link to document
2014-08-05 8 2014. The patents-in-suit in the newly-filed case (U.S. Patent Nos. 6,703,396, and 6,642,245) are also…6,703,396 and claims 1, 2, 4 and 6 of U.S. Patent No. 6,642,245. Further, Lupin intends to stipulate to … same patent claims in this action as in No. 12-cv-6293_claims 1-7, 13, 15 and 16 ofU.S. Patent No. 6,… 17 September 2014 1:14-cv-05352 830 Patent Defendant District Court, S.D External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Moodys
AstraZeneca
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.